Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 5/2014

01.08.2014 | Original Paper

Smoking behavior characteristics of non-selected smokers with childhood attention-deficit/hyperactivity disorder (AD/HD) history: a systematic review and meta-analysis

verfasst von: Guillaume Fond, Anderson Loundou, Sebastien Guillaume, Xavier Quantin, Alexandra Macgregor, Régis Lopez, Philippe Courtet, Paquito Bernard, Daniel Bailly, Mocrane Abbar, Marion Leboyer, Laurent Boyer

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

It is unclear whether adult smokers with childhood attention-deficit/hyperactivity disorder history (CH) have more severe smoking behavior than non-CH smokers, while it is clearly suggested that CH adolescents have more severe smoking behavior than CH adolescents. The aim of the present comprehensive meta-analysis is to determine whether CH smokers have more severe smoking behavior characteristics than those without and the effect of age on the association between CH and smoking behavior. We included all case–control studies and first round data collection of observational studies addressing the difference in smoking behavior characteristics of CH smokers versus non-CH smokers, with validated scales or structured interviews, without any language or date restriction. Nine studies (including 365 smokers with CH and 1,708 smokers without) were included. Compared to non-CH smokers, CH smokers smoked significantly more cigarettes [standardized mean differences (SMD) = 0.15, 95 % CI 0.01–0.28, p = 0.04] and began to regularly smoke earlier (SMD = −0.28, 95 % CI −0.49; −0.07, p = 0.01) but were not significantly more nicotine dependent (SMD = 0.23, 95 % CI −0.04 to 0.48, p = 0.08). After removing the single adolescent study, the significant association between CH and number of daily smoked cigarettes disappeared, and subgroups analyses confirmed that the significant association between CH and number of daily smoked cigarettes disappeared as age increased. Our meta-analysis illustrates a clinically important link between CH and tobacco smoking in adolescence but not later in life. Further high-quality studies are needed to confirm this finding, as only two studies included participants with a mean age below 20 years.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Bayle FJ, Krebs MO, Martin C, Bouvard MP, Wender P (2003) French version of Wender Utah Rating Scale (WURS). Can J Psychiatry 48:132PubMed Bayle FJ, Krebs MO, Martin C, Bouvard MP, Wender P (2003) French version of Wender Utah Rating Scale (WURS). Can J Psychiatry 48:132PubMed
3.
Zurück zum Zitat Berlin I, Hu MC, Covey LS, Winhusen T (2012) Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD. Drug Alcohol Depend 124:268–273PubMedCentralPubMedCrossRef Berlin I, Hu MC, Covey LS, Winhusen T (2012) Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD. Drug Alcohol Depend 124:268–273PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, Faraone SV (2012) Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 73:941–950PubMedCrossRef Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, Faraone SV (2012) Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 73:941–950PubMedCrossRef
5.
Zurück zum Zitat Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, ChichesterCrossRef Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, ChichesterCrossRef
6.
Zurück zum Zitat Bron TI, Bijlenga D, Kasander MV, Spuijbroek AT, Beekman AT, Kooij JJ (2013) Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study. Eur Neuropsychopharmacol 23:542–554PubMedCrossRef Bron TI, Bijlenga D, Kasander MV, Spuijbroek AT, Beekman AT, Kooij JJ (2013) Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study. Eur Neuropsychopharmacol 23:542–554PubMedCrossRef
7.
Zurück zum Zitat Caci HM, Bouchez J, Bayle FJ (2010) An aid for diagnosing attention-deficit/hyperactivity disorder at adulthood: psychometric properties of the French versions of two Wender Utah Rating Scales (WURS-25 and WURS-K). Compr Psychiatry 51:325–331PubMedCrossRef Caci HM, Bouchez J, Bayle FJ (2010) An aid for diagnosing attention-deficit/hyperactivity disorder at adulthood: psychometric properties of the French versions of two Wender Utah Rating Scales (WURS-25 and WURS-K). Compr Psychiatry 51:325–331PubMedCrossRef
8.
Zurück zum Zitat Covey LS, Manubay J, Jiang H, Nortick M, Palumbo D (2008) Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis. Nicotine Tob Res 10:1717–1725PubMedCentralPubMedCrossRef Covey LS, Manubay J, Jiang H, Nortick M, Palumbo D (2008) Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis. Nicotine Tob Res 10:1717–1725PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Covey LS, Hu MC, Winhusen T, Weissman J, Berlin I, Nunes EV (2010) Oros-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences. Drug Alcohol Depend 110:156–159PubMedCentralPubMedCrossRef Covey LS, Hu MC, Winhusen T, Weissman J, Berlin I, Nunes EV (2010) Oros-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences. Drug Alcohol Depend 110:156–159PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef
11.
Zurück zum Zitat Fond G, Guillaume S, Jaussent I, Beziat S, Macgregor A, Bernard P, Courtet P, Bailly D, Quantin X (2013) Prevalence and smoking behavior characteristics of nonselected smokers with childhood and/or adult self-reported ADHD symptoms in a smoking-cessation program: a cross-sectional study. J Atten Disord [Epub ahead of print] Fond G, Guillaume S, Jaussent I, Beziat S, Macgregor A, Bernard P, Courtet P, Bailly D, Quantin X (2013) Prevalence and smoking behavior characteristics of nonselected smokers with childhood and/or adult self-reported ADHD symptoms in a smoking-cessation program: a cross-sectional study. J Atten Disord [Epub ahead of print]
12.
Zurück zum Zitat Gehricke JG, Whalen CK, Jamner LD, Wigal TL, Steinhoff K (2006) The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: a preliminary examination. Nicotine Tob Res 8:37–47PubMedCrossRef Gehricke JG, Whalen CK, Jamner LD, Wigal TL, Steinhoff K (2006) The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: a preliminary examination. Nicotine Tob Res 8:37–47PubMedCrossRef
13.
Zurück zum Zitat Gehricke JG, Hong N, Wigal TL, Chan V, Doan A (2011) Adhd medication reduces cotinine levels and withdrawal in smokers with ADHD. Pharmacol Biochem Behav 98:485–491PubMedCentralPubMedCrossRef Gehricke JG, Hong N, Wigal TL, Chan V, Doan A (2011) Adhd medication reduces cotinine levels and withdrawal in smokers with ADHD. Pharmacol Biochem Behav 98:485–491PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Hammerness P, Joshi G, Doyle R, Georgiopoulos A, Geller D, Spencer T, Petty CR, Faraone SV, Biederman J (2013) Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr 162(22–27):e22CrossRef Hammerness P, Joshi G, Doyle R, Georgiopoulos A, Geller D, Spencer T, Petty CR, Faraone SV, Biederman J (2013) Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr 162(22–27):e22CrossRef
15.
Zurück zum Zitat Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86:1119–1127PubMedCrossRef Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86:1119–1127PubMedCrossRef
17.
Zurück zum Zitat Humfleet GL, Prochaska JJ, Mengis M, Cullen J, Munoz R, Reus V, Hall SM (2005) Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res 7:453–460PubMedCrossRef Humfleet GL, Prochaska JJ, Mengis M, Cullen J, Munoz R, Reus V, Hall SM (2005) Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res 7:453–460PubMedCrossRef
18.
Zurück zum Zitat Karp I, O’Loughlin J, Paradis G, Hanley J, Difranza J (2005) Smoking trajectories of adolescent novice smokers in a longitudinal study of tobacco use. Ann Epidemiol 15:445–452PubMedCrossRef Karp I, O’Loughlin J, Paradis G, Hanley J, Difranza J (2005) Smoking trajectories of adolescent novice smokers in a longitudinal study of tobacco use. Ann Epidemiol 15:445–452PubMedCrossRef
19.
Zurück zum Zitat Kollins SH, McClernon FJ, Van Voorhees EE (2010) Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD). Exp Clin Psychopharmacol 18:221–228PubMedCentralPubMedCrossRef Kollins SH, McClernon FJ, Van Voorhees EE (2010) Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD). Exp Clin Psychopharmacol 18:221–228PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Laucht M, Hohm E, Esser G, Schmidt MH, Becker K (2007) Association between ADHD and smoking in adolescence: shared genetic, environmental and psychopathological factors. J Neural Transm 114:1097–1104PubMedCrossRef Laucht M, Hohm E, Esser G, Schmidt MH, Becker K (2007) Association between ADHD and smoking in adolescence: shared genetic, environmental and psychopathological factors. J Neural Transm 114:1097–1104PubMedCrossRef
21.
Zurück zum Zitat Lee W, Bindman J, Ford T, Glozier N, Moran P, Stewart R, Hotopf M (2007) Bias in psychiatric case–control studies: literature survey. Br J Psychiatry 190:204–209PubMedCrossRef Lee W, Bindman J, Ford T, Glozier N, Moran P, Stewart R, Hotopf M (2007) Bias in psychiatric case–control studies: literature survey. Br J Psychiatry 190:204–209PubMedCrossRef
22.
Zurück zum Zitat Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH (2001) Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob Res 3:353–359PubMedCrossRef Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH (2001) Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob Res 3:353–359PubMedCrossRef
23.
Zurück zum Zitat Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMed Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMed
24.
Zurück zum Zitat Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMed Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMed
25.
Zurück zum Zitat Matthies S, Holzner S, Feige B, Scheel C, Perlov E, Ebert D, Tebartz van Elst L, Philipsen A (2013) ADHD as a serious risk factor for early smoking and nicotine dependence in adulthood. J Atten Disord 17(3):176–186. doi:10.1177/1087054711428739 Matthies S, Holzner S, Feige B, Scheel C, Perlov E, Ebert D, Tebartz van Elst L, Philipsen A (2013) ADHD as a serious risk factor for early smoking and nicotine dependence in adulthood. J Atten Disord 17(3):176–186. doi:10.​1177/​1087054711428739​
26.
Zurück zum Zitat McCann BS, Scheele L, Ward N, Roy-Byrne P (2000) Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 12:240–245PubMedCrossRef McCann BS, Scheele L, Ward N, Roy-Byrne P (2000) Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 12:240–245PubMedCrossRef
27.
Zurück zum Zitat McClernon FJ, Kollins SH, Lutz AM, Fitzgerald DP, Murray DW, Redman C, Rose JE (2008) Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology 197:95–105PubMedCrossRef McClernon FJ, Kollins SH, Lutz AM, Fitzgerald DP, Murray DW, Redman C, Rose JE (2008) Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology 197:95–105PubMedCrossRef
28.
Zurück zum Zitat McClernon FJ, Van Voorhees EE, English J, Hallyburton M, Holdaway A, Kollins SH (2011) Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial. Nicotine Tob Res 13:784–792PubMedCentralPubMedCrossRef McClernon FJ, Van Voorhees EE, English J, Hallyburton M, Holdaway A, Kollins SH (2011) Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial. Nicotine Tob Res 13:784–792PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Modesto-Lowe V, Danforth JS, Neering C, Easton C (2010) Can we prevent smoking in children with ADHD: a review of the literature. Conn Med 74:229–236PubMed Modesto-Lowe V, Danforth JS, Neering C, Easton C (2010) Can we prevent smoking in children with ADHD: a review of the literature. Conn Med 74:229–236PubMed
31.
Zurück zum Zitat Monuteaux MC, Spencer TJ, Faraone SV, Wilson AM, Biederman J (2007) A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. J Clin Psychiatry 68:1094–1101PubMedCrossRef Monuteaux MC, Spencer TJ, Faraone SV, Wilson AM, Biederman J (2007) A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. J Clin Psychiatry 68:1094–1101PubMedCrossRef
32.
Zurück zum Zitat Palmer RH, Knopik VS, Rhee SH, Hopfer CJ, Corley RC, Young SE, Stallings MC, Hewitt JK (2013) Prospective effects of adolescent indicators of behavioral disinhibition on DSM-IV alcohol, tobacco, and illicit drug dependence in young adulthood. Addict Behav 38:2415–2421PubMedCrossRef Palmer RH, Knopik VS, Rhee SH, Hopfer CJ, Corley RC, Young SE, Stallings MC, Hewitt JK (2013) Prospective effects of adolescent indicators of behavioral disinhibition on DSM-IV alcohol, tobacco, and illicit drug dependence in young adulthood. Addict Behav 38:2415–2421PubMedCrossRef
33.
Zurück zum Zitat Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF (2003) Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addict Behav 28:1149–1157PubMedCrossRef Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF (2003) Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addict Behav 28:1149–1157PubMedCrossRef
34.
Zurück zum Zitat Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rossler M (2002) Wender Utah Rating Scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults. Nervenarzt 73:830–838PubMedCrossRef Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rossler M (2002) Wender Utah Rating Scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults. Nervenarzt 73:830–838PubMedCrossRef
35.
Zurück zum Zitat Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Georg T, Supprian T, Wender PH, Rosler M (2003) Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder. Nervenarzt 74:987–993PubMedCrossRef Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Georg T, Supprian T, Wender PH, Rosler M (2003) Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder. Nervenarzt 74:987–993PubMedCrossRef
36.
Zurück zum Zitat Romo L, Legauffre C, Mille S, Cheze N, Fougeres AL, Marquez S, Excoffier A, Dubertret C, Ades J (2010) Psychometric properties of the French version of the Wender Utah Rating Scale and brown’s attention deficit disorders scale for adults. Encephale 36:380–389PubMedCrossRef Romo L, Legauffre C, Mille S, Cheze N, Fougeres AL, Marquez S, Excoffier A, Dubertret C, Ades J (2010) Psychometric properties of the French version of the Wender Utah Rating Scale and brown’s attention deficit disorders scale for adults. Encephale 36:380–389PubMedCrossRef
37.
Zurück zum Zitat Rossini ED, O’Connor MA (1995) Retrospective self-reported symptoms of attention-deficit hyperactivity disorder: reliability of the Wender Utah Rating Scale. Psychol Rep 77:751–754PubMedCrossRef Rossini ED, O’Connor MA (1995) Retrospective self-reported symptoms of attention-deficit hyperactivity disorder: reliability of the Wender Utah Rating Scale. Psychol Rep 77:751–754PubMedCrossRef
38.
Zurück zum Zitat Rush CR, Higgins ST, Vansickel AR, Stoops WW, Lile JA, Glaser PE (2005) Methylphenidate increases cigarette smoking. Psychopharmacology 181:781–789PubMedCrossRef Rush CR, Higgins ST, Vansickel AR, Stoops WW, Lile JA, Glaser PE (2005) Methylphenidate increases cigarette smoking. Psychopharmacology 181:781–789PubMedCrossRef
39.
Zurück zum Zitat Stein MA, Sandoval R, Szumowski E, Roizen N, Reinecke MA, Blondis TA, Klein Z (1995) Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women. Psychopharmacol Bull 31:425–433PubMed Stein MA, Sandoval R, Szumowski E, Roizen N, Reinecke MA, Blondis TA, Klein Z (1995) Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women. Psychopharmacol Bull 31:425–433PubMed
40.
Zurück zum Zitat Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002PubMedCrossRef Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002PubMedCrossRef
41.
Zurück zum Zitat Stoops WW, Poole MM, Vansickel AR, Hays KA, Glaser PE, Rush CR (2011) Methylphenidate increases choice of cigarettes over money. Nicotine Tob Res 13:29–33PubMedCentralPubMedCrossRef Stoops WW, Poole MM, Vansickel AR, Hays KA, Glaser PE, Rush CR (2011) Methylphenidate increases choice of cigarettes over money. Nicotine Tob Res 13:29–33PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Tercyak KP, Audrain-McGovern J (2003) Personality differences associated with smoking experimentation among adolescents with and without comorbid symptoms of ADHD. Subst Use Misuse 38:1953–1970PubMedCrossRef Tercyak KP, Audrain-McGovern J (2003) Personality differences associated with smoking experimentation among adolescents with and without comorbid symptoms of ADHD. Subst Use Misuse 38:1953–1970PubMedCrossRef
43.
Zurück zum Zitat Vansickel AR, Stoops WW, Glaser PE, Poole MM, Rush CR (2011) Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology (Berl) 218(2):381–390. doi:10.1007/s00213-011-2328-y CrossRef Vansickel AR, Stoops WW, Glaser PE, Poole MM, Rush CR (2011) Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology (Berl) 218(2):381–390. doi:10.​1007/​s00213-011-2328-y CrossRef
44.
Zurück zum Zitat Vassos E, Collier DA, Fazel S (2013) Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression. Mol Psychiatry. doi:10.1038/mp.2013.31 Vassos E, Collier DA, Fazel S (2013) Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression. Mol Psychiatry. doi:10.​1038/​mp.​2013.​31
45.
Zurück zum Zitat Ward MF, Wender PH, Reimherr FW (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885–890PubMed Ward MF, Wender PH, Reimherr FW (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885–890PubMed
46.
Zurück zum Zitat Wheeler TL, Smith LN, Bachus SE, McDonald CG, Fryxell KJ, Smith RF (2013) Low-dose adolescent nicotine and methylphenidate have additive effects on adult behavior and neurochemistry. Pharmacol Biochem Behav 103:723–734PubMedCrossRef Wheeler TL, Smith LN, Bachus SE, McDonald CG, Fryxell KJ, Smith RF (2013) Low-dose adolescent nicotine and methylphenidate have additive effects on adult behavior and neurochemistry. Pharmacol Biochem Behav 103:723–734PubMedCrossRef
47.
Zurück zum Zitat Wilens TE, Vitulano M, Upadhyaya H, Adamson J, Sawtelle R, Utzinger L, Biederman J (2008) Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr 153(3):414–419. doi:10.1016/j.jpeds.2008.04.030 Wilens TE, Vitulano M, Upadhyaya H, Adamson J, Sawtelle R, Utzinger L, Biederman J (2008) Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr 153(3):414–419. doi:10.​1016/​j.​jpeds.​2008.​04.​030
48.
Zurück zum Zitat Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM (2010) Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 71:1680–1688PubMedCentralPubMedCrossRef Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM (2010) Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 71:1680–1688PubMedCentralPubMedCrossRef
49.
Zurück zum Zitat Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC (2011) Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 21:455–463PubMedCentralPubMedCrossRef Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC (2011) Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 21:455–463PubMedCentralPubMedCrossRef
Metadaten
Titel
Smoking behavior characteristics of non-selected smokers with childhood attention-deficit/hyperactivity disorder (AD/HD) history: a systematic review and meta-analysis
verfasst von
Guillaume Fond
Anderson Loundou
Sebastien Guillaume
Xavier Quantin
Alexandra Macgregor
Régis Lopez
Philippe Courtet
Paquito Bernard
Daniel Bailly
Mocrane Abbar
Marion Leboyer
Laurent Boyer
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 5/2014
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-014-0497-5

Weitere Artikel der Ausgabe 5/2014

European Archives of Psychiatry and Clinical Neuroscience 5/2014 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.